HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

How does antifungal pharmacology differ for mucormycosis versus aspergillosis?

Abstract
Over the last decade, advances in diagnostic systems and the introduction of new antifungal agents have significantly improved outcomes in immunocompromised patients who develop invasive aspergillosis. However, mortality rates remain relatively unchanged for less common, but highly aggressive, mold infections such as mucormycosis. Recent genome sequencing of Rhizopus oryzae revealed evidence of a whole-genome duplication event during the evolution of this pathogen. Consequently, R. oryzae has a 2- to 10-fold enrichment in gene families associated with ergosterol and cell wall biosynthesis, cell growth, iron uptake, and known fungal virulence factors compared with sequenced Aspergillus fumigatus strains. This genetic plasticity may explain the remarkable capability of this pathogen for rapid growth in hostile environments, such as the inflammatory milieu, as well as its relative resistance to multiple antifungal classes. Herein, we examine how pharmacological aspects of treating mucormycosis may differ from those of the more commonly encountered invasive aspergillosis.
AuthorsRussell E Lewis, Olivier Lortholary, Brad Spellberg, Emmanuel Roilides, Dimitrios P Kontoyiannis, Thomas J Walsh
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 54 Suppl 1 Pg. S67-72 (Feb 2012) ISSN: 1537-6591 [Electronic] United States
PMID22247448 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Virulence Factors
  • Itraconazole
  • Amphotericin B
  • Voriconazole
  • Ergosterol
Topics
  • Amphotericin B (pharmacology)
  • Antifungal Agents (pharmacology)
  • Aspergillosis (drug therapy, microbiology)
  • Aspergillus (genetics, pathogenicity)
  • Cell Membrane (genetics, metabolism)
  • Cell Wall (genetics, metabolism)
  • Drug Resistance, Multiple, Fungal
  • Ergosterol (biosynthesis, genetics)
  • Gene Duplication
  • Genome, Fungal
  • Genomic Instability
  • Humans
  • Itraconazole (pharmacology)
  • Microbial Sensitivity Tests
  • Mucormycosis (drug therapy, microbiology)
  • Pyrimidines (pharmacology)
  • Rhizopus (genetics, growth & development, metabolism, pathogenicity)
  • Species Specificity
  • Triazoles (pharmacology)
  • Virulence Factors (genetics, metabolism)
  • Voriconazole

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: